Stryker (NYSE: SYK) reported earnings on April 24. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Stryker met expectations on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue grew slightly. Non-GAAP earnings per share increased. GAAP earnings per share dropped.

Margins dropped across the board.

Revenue details
 Stryker notched revenue of $2.19 billion. The 28 analysts polled by S&P Capital IQ foresaw revenue of $2.20 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.03. The 30 earnings estimates compiled by S&P Capital IQ predicted $1.01 per share. Non-GAAP EPS of $1.03 for Q1 were 4.0% higher than the prior-year quarter's $0.99 per share. GAAP EPS of $0.79 for Q1 were 13% lower than the prior-year quarter's $0.91 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 67.4%, 40 basis points worse than the prior-year quarter. Operating margin was 18.3%, 580 basis points worse than the prior-year quarter. Net margin was 13.9%, 230 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $2.20 billion. On the bottom line, the average EPS estimate is $1.04.

Next year's average estimate for revenue is $8.99 billion. The average EPS estimate is $4.31.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,427 members out of 1,459 rating the stock outperform, and 32 members rating it underperform. Among 439 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 433 give Stryker a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Stryker is outperform, with an average price target of $65.33.

Is Stryker the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.